Literature DB >> 23568164

In search of the molecular consequences of 8p21 deletion in multiple myeloma: commentary on Gmidéne et al.

Tolga Sutlu, Evren Alici, Gösta Gahrton, Hareth Nahi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23568164     DOI： 10.1007/s12032-013-0569-9

Source DB:  PubMed          Journal:  Med Oncol        ISSN： 1357-0560            Impact factor:   3.064


× No keyword cloud information.
  6 in total

1.  The prognostic significance of 8p21 deletion in multiple myeloma.

Authors:  T Sutlu; E Alici; M Jansson; A Wallblom; M S Dilber; G Gahrton; H Nahi
Journal:  Br J Haematol       Date:  2008-11-11       Impact factor: 6.998

2.  TRAIL is a potent inducer of apoptosis in myeloma cells derived from multiple myeloma patients and is not cytotoxic to hematopoietic stem cells.

Authors:  Y Gazitt
Journal:  Leukemia       Date:  1999-11       Impact factor: 11.528

3.  Combining information regarding chromosomal aberrations t(4;14) and del(17p13) with the International Staging System classification allows stratification of myeloma patients undergoing autologous stem cell transplantation.

Authors:  Kai Neben; Anna Jauch; Uta Bertsch; Christiane Heiss; Thomas Hielscher; Anja Seckinger; Tina Mors; Nadine Zoe Müller; Jens Hillengass; Marc S Raab; Anthony D Ho; Dirk Hose; Hartmut Goldschmidt
Journal:  Haematologica       Date:  2010-03-10       Impact factor: 9.941

Review 4.  Clinical impact of chromosomal aberrations in multiple myeloma.

Authors:  H Nahi; T Sutlu; M Jansson; E Alici; G Gahrton
Journal:  J Intern Med       Date:  2010-12-15       Impact factor: 8.989

5.  8p21.3 deletion suggesting a probable role of TRAIL-R1 and TRAIL-R2 as candidate tumor suppressor genes in the pathogenesis of multiple myeloma.

Authors:  A Gmidène; A Saad; H Avet-Loiseau
Journal:  Med Oncol       Date:  2013-02-20       Impact factor: 3.064

6.  Critical role for tumor necrosis factor-related apoptosis-inducing ligand in immune surveillance against tumor development.

Authors:  Kazuyoshi Takeda; Mark J Smyth; Erika Cretney; Yoshihiro Hayakawa; Nobuhiko Kayagaki; Hideo Yagita; Ko Okumura
Journal:  J Exp Med       Date:  2002-01-21       Impact factor: 14.307
  6 in total
  1 in total

1.  Deletion of Chromosomal Region 8p21 Confers Resistance to Bortezomib and Is Associated with Upregulated Decoy TRAIL Receptor Expression in Patients with Multiple Myeloma.

Authors:  Adil Doganay Duru; Tolga Sutlu; Ann Wallblom; Katarina Uttervall; Johan Lund; Birgitta Stellan; Gösta Gahrton; Hareth Nahi; Evren Alici
Journal:  PLoS One       Date:  2015-09-17       Impact factor: 3.240
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.